Livzon Pharmaceutical Group Inc. at its Extraordinary General Meeting of 2022 held on 21 June 2023, approved Election and nomination of Xu Guoxiang, executive director, as non-independent directors, Election and nomination of Huang Jinhua as independent directors and Election of Huang Huamin, Tang Yin as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.7 CNY | -0.15% | +1.36% | +10.54% |
05-27 | Livzon Pharmaceutical Cancels 5.3 Million Share Options | MT |
05-14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.54% | 4.34B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Announces Directorate Appointments